Here we review current guidelines on breast and ovarian cancer screening, prophylactic surgery, and other risk-reduction strategies in patients with these mutations, and we detail the data that drive these recommendations.
Christine Stanislaw, MS, CGC
Advertisement
Articles by Christine Stanislaw, MS, CGC
Advertisement
Latest Updated Articles
- Prevention and Screening in Hereditary Breast and Ovarian Cancer
Published: October 16th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
